The AECC DMA Sequencing Shared Resource was established in 1992 and has evolved considerably sincethen and, in particular, over the last funding period, to meet the evolving scientific needs of AECC membersand programs. The new name of this facility, Genomics Shared Resource, reflects this expansion of servicesand technologies. The facility now offers, in addition to DMA sequencing, fragment analysis, dHPLC forSNP/mutation discovery, Pyrosequencing SNP typing, pyrosequencing quantitative CpG methylation, andTaqman SNP typing. Real-time PCR is now provided as well. At the time of the last CCSG review, thisFacility provided Affymetrix services, and there was a separate cDNA printing facility. With the furtherdevelopment of microarray technologies, there has been a shift of emphasis to commercially availablemicroarrays. To meet the needs for epigenetic studies, services were contracted with NimbleGen Direct toperform, on their site, gene expression, CGH, chromatin immunoprecipitation on microarrays (ChlP-chip),and a novel genome-wide cytosine methylation assay developed at AECC. NimbleGen services aremanaged by this facility. Within the context of this application all of the microarray services (Affymetrix,NimbleGen and in-house printing) have now been consolidated in this shared resource to provide a singlesource of intellectual guidance to users and enhance cost-effectiveness. The facility provides access to threecomputer workstations with design and analysis software to support a number of the services. Over the pastfive years the capacity of the facility has been increased so that turnaround time has been substantiallydecreased and fees to users have been decreased.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Bines, Jose; Tevaarwerk, Amye J (2018) Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy. Cancer :
Mathew, Deepti; Wang, Yanhua; Van Arsdale, Anne et al. (2018) Expression of ?V-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia. Int J Gynecol Cancer 28:363-370
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :
De Martino, Daniela; Yilmaz, Emrullah; Orlacchio, Arturo et al. (2018) PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer. Cancer Lett 439:56-65
Norwood Toro, Laura E; Wang, Yarong; Condeelis, John S et al. (2018) Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis. Exp Cell Res 370:273-282
Agalliu, Ilir; Chen, Zigui; Wang, Tao et al. (2018) Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev 27:1168-1175
Bhargava, Ragini; Sandhu, Manbir; Muk, Sanychen et al. (2018) C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun 9:2484

Showing the most recent 10 out of 1508 publications